Peer Review History
| Original SubmissionAugust 6, 2024 |
|---|
|
PONE-D-24-31353The state of iodine deficiency in Kyrgyzstan: insights from studies of knowledge, attitudes and practicesPLOS ONE Dear Dr. Dzhusupov, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 04 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ramesh Athe, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The MS ID # PONE-D-24-31353 titled “The state of iodine deficiency in Kyrgyzstan: insights from studies of knowledge, attitudes and practices” by Kenesh Dzhusupov et al., identified significant knowledge gap related to iodine nutrition and in the Kyrgyzstan population. Although the results are encouraging, The following minor comments could be addressed before the manuscript acceptance for publication. 1. The figures in poor quality and hard to review. 2. Not clear whether the thyroid hormone levels and other health issues associated with UIC in these subjects? 3. Not sure whether the IDD in sub clinical or clinical level? 4. Is there any relationship between of low iodine and economic status? Reviewer #2: Thanks for the opportunity to review the manuscript titled as “The state of iodine deficiency in Kyrgyzstan: insights from studies of knowledge, attitudes and practices (PONE-D-24-31353). The paper is quiet interesting and of intriguing interest in the maternal and child healthcare issues and concern. Though the paper is quiet relevant in the contemporary times, I have certain concerns and queries which needs to be addressed by the authors. The comments are listed in detail as under: 1. The introduction effectively sets the stage for the study. However, it could be improved by discussing the potential impact of cultural factors on iodine deficiency and how this study addresses those factors. 2. The literature cited is comprehensive, but more recent studies on iodine deficiency and interventions could be included. This would help contextualize the findings within the broader global effort to combat iodine deficiency. 3. The methodology is robust, but more details about the training of data collectors and the validation process of the questionnaire would enhance the reliability of the data. Additionally, the rationale for the chosen statistical methods should be explained in more detail. 4. The sampling method is well described, but it might be helpful to clarify how the pilot study influenced the final design of the questionnaire. Were there any significant changes based on the pilot study results? 5. The multivariate regression model used to assess predictors of urinary iodine concentration (UIC) includes several variables (residence, knowledge, attitudes, practices, etc.). However, there is no mention of how multicollinearity between these predictors was assessed. Multicollinearity can inflate standard errors and make it difficult to determine the significance of individual predictors. 6. The study uses knowledge, attitude, and practice (KAP) scores as continuous variables in the regression analysis. While this is appropriate, the paper does not discuss whether these scores meet the assumptions of normality required for regression analysis. Additionally, the urinary iodine concentration (UIC) is also treated as a continuous variable, and its distribution is not examined. 7. The presentation of the results is clear, but some sections could benefit from more detailed explanations. For example, in Table 3, it would be helpful to briefly explain the significance of the KAP scores and how they relate to each other in the text. 8. Consider improving the readability of figures and tables. For example, Fig 4 (Relationships between KAP scores and UIC) could be more informative if the axes were labelled more clearly and the relationship explained in more detail within the figure caption. 9. The discussion could be more concise. While it effectively interprets the findings, it tends to repeat points already made in the results section. Focus on the most critical findings and their implications. 10. The discussion effectively highlights the gaps in knowledge and practices. However, it would be beneficial to compare the findings with other similar regions to give a more global perspective. Also, discussing the limitations in greater detail, particularly the cross-sectional design and potential biases, would strengthen the paper. 11. Though the paper is structured properly, and the objectives are clear. However, the discussion section could benefit from more concise and focused arguments. Streamlining the findings and their implications will help the reader better understand the key takeaways. 12. The conclusions are sound but could be more actionable. It would be helpful to provide specific recommendations for policy changes or interventions based on the study’s findings. The conclusion should include more specific recommendations for public health interventions. Additionally, emphasizing the importance of ongoing monitoring and the role of healthcare providers in education could strengthen this section. 13. While the language is generally clear, there are a few areas where sentences could be simplified for better readability. Proofreading for minor grammatical errors is recommended. 14. Ensure that all references are up-to-date and relevant to the study. Some references could be replaced with more recent studies if available. The paper provides valuable insights into iodine deficiency in Kyrgyzstan, but it could be enhanced by clarifying the discussion, offering more actionable conclusions, and ensuring all methods and data are transparently presented. Overall, it is a well-executed study that could significantly contribute to public health interventions in the region. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The state of iodine deficiency in Kyrgyzstan: insights from studies of knowledge, attitudes and practices PONE-D-24-31353R1 Dear Dr. Dzhusupov, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ramesh Athe, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-31353R1 PLOS ONE Dear Dr. Dzhusupov, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ramesh Athe Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .